Difference Between Medical and Nonmedical Students on Knowledge, Practice, and Attitude Towards the Human Papillomavirus Vaccine in China: a Cross-Sectional Study

被引:0
作者
Yingnan Liu
Xingyuan Jiang
Lingyi Xu
Na Di
Lu Jiang
Xia Tao
机构
[1] Peking University First Hospital,Department of Obstetrics and Gynecology
来源
Journal of Cancer Education | 2021年 / 36卷
关键词
HPV vaccine; Knowledge; Practice; Attitude; Medical and nonmedical students; China;
D O I
暂无
中图分类号
学科分类号
摘要
HPV vaccine can prevent HPV infection effectively. The college student’s vaccination status is unclear in mainland China. We assessed the knowledge, practice, and attitude towards HPV vaccine and compared the differences between medical and nonmedical students. It was a cross-sectional study using self-administered anonymous questionnaires. Nine-hundred sixty full-time college students were recruited randomly at Peking University in China. The medical students had higher level of knowledge of HPV and its vaccine than the nonmedical students (p < 0.001). The vaccinated female students were 9.0%. The high-grade clinical students had a higher uptake rate than the nonmedical students (19.5 vs 8.6%, p < 0.05). Awareness of HPV (p < 0.01), awareness of the vaccine (p < 0.001), and vaccinated family members or friends (p < 0.001) were related to the nonmedical students’ vaccination. Vaccinated family members or friends were significant predictor for students’ vaccination status (p < 0.001). Medical students knew more about HPV and its vaccine than nonmedical students. Female students’ vaccinated rate was low, and the high-grade clinical students had a higher uptake rate than the nonmedical students.
引用
收藏
页码:1014 / 1021
页数:7
相关论文
共 187 条
  • [1] Torre LA(2015)Global cancer statistics, 2012[J] CA Cancer J Clin 65 87-108
  • [2] Bray F(2016)Cancer statistics in China, 2015[J] CA Cancer J Clin 66 115-132
  • [3] Siegel RL(2010)Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J] Lancet Oncol 11 1048-1056
  • [4] Ferlay J(2007)Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases[J] N Engl J Med 356 1928-1943
  • [5] Lortet-Tieulent J(2009)Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women[J] Lancet 374 301-314
  • [6] Jemal A(2015)A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women[J] N Engl J Med 372 711-723
  • [7] Chen W(2014)Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).[J] MMWR Recomm Rep 63 1-30
  • [8] Zheng R(2018)Knowledge and attitudes regarding HPV and vaccination among Chinese women aged 20 to 35 years in Fujian Province[J] Cancer Control 25 544117791-3634
  • [9] Baade PD(2018)Assessing university students' sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior[J] Vaccine 36 3629-310
  • [10] Zhang S(2018)Chinese medical students’ knowledge, attitude and practice towards human papillomavirus vaccination and their intention to recommend the vaccine[J] J Paediatr Child Health 54 302-1007